Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Innovate Biopharmaceuticals Inc.
INNT
Healthcare
Biotechnology
"Innovate Biopharmaceuticals Inc is a clinical stage biotechnology company. The company is engaged in developing novel medicines for an autoimmune/ inflammatory disease. It includes drug candidates for celiac disease, NASH, Crohn's, and ulcerative colitis."
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:INNT)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
Next
(26)
•••
kalareta
X
View Profile
View Bullboard History
Comment by
kalareta
on May 13, 2020 9:33am
RE:First Analyst Day tomorrow
In what time frame 14 dol. is coming?
(668)
•••
coolfooldumbguy
X
View Profile
View Bullboard History
Post by
coolfooldumbguy
on Jan 29, 2020 8:53pm
slow to react to buy this one originally
it's my fault because this month was hectic for me with personal stuff going on,but things are settled down for me now,and will probably add more shares here on weakness,so glta shareholders.
Mandalay Extends the Storheden Gold Deposit Adjacent to the Operating Björkdal Mine
posted Apr 29, 2024 9:00am by
Mandalay Resources Corp.
-
|
"I am pleased to share progress on our 2023 initiatives at Storheden. This deposit has not been thoroughly explored in comparison to our extensive Björkdal deposit however it is showing promising signs of gold mineralization. In 2023, about 5,150 m were drilled across 22 drillholes targeting two separate objectives: depth extension with verification of system geometries and strike extension of the shear system ...read more
(668)
•••
coolfooldumbguy
X
View Profile
View Bullboard History
Post by
coolfooldumbguy
on Jan 23, 2020 10:14am
it's a buy today for me
at .87 cents per share,so glta shareholders.
(668)
•••
coolfooldumbguy
X
View Profile
View Bullboard History
Post by
coolfooldumbguy
on Jan 02, 2020 11:13am
the bottom is past for
this one,may be a possible buy for me soon,so glta.
Prev
1
2
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Fresh Insight into the Topaz HELIUM Project's Expected Size and Scale
Exploration company provides project portfolio update
This Gambling Tech Stock is Future-Proofing the World’s Casinos and has No Direct Competition
Mullen Group Ltd. Reports 2024 First Quarter Financial Results